Abstract
Background Venous thrombosis is common in knee surgery, and it has been assumed that vein occlusion by tourniquet in itself may induce thrombogenic and fibrinolytic activity. Prophylactic treatment is used up to 12 h before or after surgery, and recent clinical trials suggest that the timing of initiating prophylaxis significantly influences antithrombotic effectiveness. Materials and methods We studied the time course of coagulation and fibrinolysis locally and systemically during total knee arthroplasty. Specific markers of thrombosis (prothrombin fragment 1.2 (F1.2)) and fibrinolysis (plasmin-antiplasmin (PAP) and D-dimer) were examined in seven female and two male patients. Results There were no systemic activations of either F1.2 (P = 0.314), PAP (P = 0.314) or D-dimer (P = 0.600) during surgery or at 10 min postoperatively (P = 0.139, 0.139 and 0.128, respectively) as compared to baseline data. At 4 h postoperatively there were significant increments in levels of F1.2 (P = 0.008), PAP (P = 0.038) and D-dimer (P = 0.046). With tourniquet deflation the values of F1.2, PAP and D-dimer were significantly higher in the tourniquet limb than the in the contra lateral limb (P = 0.025, 0.012 and 0.028, respectively). At 10 min after tourniquet deflation, the differences in F1.2, PAP and D-dimer between the two limbs were not significant. Conclusion The use of tourniquet in total knee arthroplasty causes local thrombogenic and fibrinolytic activity, but without influences in the systemic circulation. Systemic activations in thrombosis and fibrinolysis start when local mediators from the injured limb are released after tourniquet deflation.
Similar content being viewed by others
References
Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119:132S–175S. doi:10.1378/chest.119.1_suppl.132S
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593. doi:10.1001/archinte.158.6.585
Pini M, Spyropoulos AC (2006) Prevention of venous thromboembolism. Semin Thromb Hemost 32:755–766. doi:10.1055/s-2006-955458
Weinmann EE, Salzman EW (1994) Deep-vein thrombosis. N Engl J Med 331:1630–1641. doi:10.1056/NEJM199412153312407
Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(Suppl 3):338S–400S
Sharnoff JG, DeBlasio G (1970) Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 2:1006–1007
Gallus AS, Hirsh J, Tuttle RJ, McBride JA, Tuttle RJ, Gent M (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545–551
Dahl OE, Aspelin T, Lyberg T (1995) The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigs. Blood Coagul Fibrinolysis 6:709–717
Dahl OE, Andreassen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, Abdelnoor M, Arnesen H (1997) Prolonged thromboprophylaxis following hip replacement surgery: results of a double-blind prospective, randomized, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 77:26–31
Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA (1999) Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 159:137–141
Turpie AGG, Levine MN, Hirsh J (1986) A randomized controlled trial of a low- molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315:925–929
Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J (1991) Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 114:545–551
Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA (1994) Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement: a clinical trial comparing efficacy and safety. J Bone Joint Surg (A) 76:3–14
Spiro TE, Johnson CJ, Christie MJ (1994) Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med 121:81–89
Kearon C, Hirsh J (1995) Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 155:366–372
Insall JN, Haas SB (1993) Complications of total knee arthroplasty. In: Insall JN (ed) Surgery of the knee. Churchill Livingstone, New York, pp 891–894
Westrich GH, Menezes A, Sharrock N, Sculco TP (1999) Thromboembolic disease prophylaxis in total knee arthroplasty using intraoperative heparin and postoperative pneumatic foot compression. J Arthroplast 14:651–656
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S–453S
Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA (1995) Thrombognenesis during hip arthroplasty. Clin Othop Rel Res 319:16–27
Conway EM, Bauer KA, Barzegar S, Riosenberg RD (1987) Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 80:1535–1544
Boneu B, Bes G, Pelzer H, Sie P, Bocxcalon H (1991) D-dimers, thrombin antithrombin III complexes and prothrombin fragment 1 + 2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 65:28–32
Abdel-Salam A, Eyres KS (1995) Effects of tourniquet during total knee arthroplasty A prospective randomised study. J Bone Joint Surg (Br) 77:250–253
Doouss T (1976) The clinical significance of venous thrombosis of the calf. Br J Surg 63:377–378
Katsumata S, Nagashima M, Kato K, Tachihara A, Wauke K, Saito S, Jin E, Kawanami O, Ogawa R, Yoshino S (2005) Changes in coagulation-fibrinolysis marker and neutrophil elastase following the use of tourniquet during total knee arthroplasty and the influence of neutrophil elastase on thromboembolism. Acta Anaesthes Scand 49:510–516
Petaja J, Myllynen P, Myllyla G, Vahtera E (1987) Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 153:647–651
Klenerman L, Chakrabarti R, Mackie I, Brozovic M, Stirling Y (1977) Changes in haemostatic system after application of a tourniquet. Lancet 1(8019):970–972
Sharrock NE, Og G, Williams-Russo P, Haas SB, Harpel PC (1977) Comparison of extradural and general anaesthesia on the fibrinolytic response to total knee arthroplasty. Br J Anaesth 79:29–34
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reikerås, O., Clementsen, T. Time course of thrombosis and fibrinolysis in total knee arthroplasty with tourniquet application. Local versus systemic activations. J Thromb Thrombolysis 28, 425–428 (2009). https://doi.org/10.1007/s11239-008-0299-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-008-0299-6